Beam Therapeutics Inc.BEAMNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P13
Within normal range
vs 5Y Ago
-1.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -9.56% |
| Q3 2025 | 7.87% |
| Q2 2025 | 2.98% |
| Q1 2025 | -2.59% |
| Q4 2024 | 7.62% |
| Q3 2024 | 8.29% |
| Q2 2024 | 2.62% |
| Q1 2024 | -39.45% |
| Q4 2023 | 40.01% |
| Q3 2023 | 2.50% |
| Q2 2023 | -2.05% |
| Q1 2023 | 15.41% |
| Q4 2022 | 1.24% |
| Q3 2022 | 14.39% |
| Q2 2022 | 13.98% |
| Q1 2022 | -32.41% |
| Q4 2021 | 77.18% |
| Q3 2021 | 19.85% |
| Q2 2021 | -76.03% |
| Q1 2021 | 485.82% |
| Q4 2020 | 8.80% |
| Q3 2020 | 54.10% |
| Q2 2020 | -10.19% |
| Q1 2020 | 6.59% |
| Q4 2019 | 61.18% |
| Q3 2019 | -1.08% |
| Q2 2019 | 38.14% |
| Q1 2019 | -6.83% |
| Q4 2018 | -0.02% |
| Q3 2018 | 39.11% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |